Intervention

Lymfactin® (1x10E11 vp)

ClinicalTrials.gov intervention label

Clinical trials1

Recruiting0

Common conditions1

Lead sponsors shown1

Clinical trials

1 shown

Clinical Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema (AdeLE)NCT03658967 · 2018-06-07

COMPLETED

Common conditions

Secondary Lymphedema1

Leading sponsors

Herantis Pharma Plc.1

Trial status mix

COMPLETED1

Phase mix

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.